SureTrader Advertisement Advertisement
Home > Boards > Stock Clubs > Long-Term > WOMENS STOCKS


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DEMO P2 Member Profile
Followed By 153
Posts 32,227
Boards Moderated 1
Alias Born 03/01/07
160x600 placeholder
Sampo Oyj Sampo Plc: Disclosure Under Chapter 9 Section 5 Of The Securities Market Act
Subscribe to WSJ: (END) Dow Jones Newswires November 30, 2015 02:31 ET (07:31 GMT)
Correction to Barron's Friday Blog Item on Pfizer-Allergan
BHP Says Yet to Receive Suit Planned by Brazil Over Dam Spill
Wal-Mart, Neiman Marcus Sites Have Black Friday Hiccups--Update
Activists Display Lighter Touch
Toshiba Mulls Sale of Stake in Chip Arm
SunEdison's TerraForm Affiliates Shake Up Management
BofA Executive Leaves Firm
Alcoa Reaches Deal With New York to Save Jobs at Smelter
H-P Spinoffs Give First Looks
DEMO P2   Thursday, 05/17/07 08:19:42 AM
Re: None
Post # of 51 

Email this Release | Printer-Friendly


Pharm Control Shareholder Update
NEW YORK, NY -- (MARKET WIRE) -- May 16, 2007 -- The Board of Directors of Pharm Control Ltd. (PINKSHEETS: PMCL) has decided to dividend out to shareholders one new share of Natural Medicines AG for every three shares of Pharm Control Ltd. held by shareholders of record on Friday, July 13, 2007.

Discussions with European investment bankers have revealed to Company management that the anticipated trading level for the new European entity will be in the area of 0.25 Euros.

This dividend will be paid after the 8 new for 5 old dividend payment of Pharm Control Ltd. at the end of June.

Pharm Control Ltd.'s management anticipates the name change and CUSIP number change to become effective any day now and will follow up with another shareholder update along with the name of the new transfer agent once all is completed.

About Pharm Control Ltd.

Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.

Safe Harbor Statement

The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.


Pharm Control Ltd.
Eugene Kron
Vice President
Tel: (212) 252-4521

SOURCE: Pharm Control Ltd.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist